Quality assessment of clinical practice guidelines for benign prostatic hyperplasia_Chinese Journal of Evidence-Based Medicine

Authors：

LI Sheng ¹ , ZENG Xiantao ¹ , LI Xiaodong ² , WU Kaijie ³ , ZI Hao ² ,  HE Dalin ³ ,  WANG Xinghuan ¹

1. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P.R.China;
2. Department of Urology, Huaihe Hospital of Henan University, Kaifeng, 475000, P.R.China;
3. Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, P.R.China;

Corresponding?author：

HE Dalin, Email: held@mail.xjtu.edu.cn; WANG Xinghuan, Email: wangxinghuan@whu.edu.cn

Keywords：

Benign prostatic hyperplasia; Clinical practice guideline; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.201704003

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To evaluate the methodological quality of published clinical practice guidelines for benign prostatic hyperplasia. Methods PubMed, EMbase, CNKI, WanFang Data, VIP and CBM databases, website of Yimaitong, and international authoritative guide platforms were electronically searched to collect the relevant clinical practice guidelines or consensus for benign prostate hyperplasia. The retrieval covered the time up to December 13^th, 2016. Literatures were independently screened by 2 reviewers. After data extraction, the methodological quality of included guidelines was evaluated by 4 reviewers using the AGREE Ⅱ. Each domain score was calculated and the intraclass correlation coefficient was used to evaluate the consistency among the reviewers. Results A total of 15 clinical practice guidelines were included. The mean scores for the six domains in AGREE Ⅱ were: 72%, 38%, 30%, 58%, 16%, and 40%, respectively. The intraclass correlation coefficient was larger than 0.87, which indicated the total consistency was well. Conclusions The quality of clinical practice guidelines for benign prostatic hyperplasia is not satisfactory as expected. They are heterogeneous in quality and some requires improvement. Guidelines are required to be further developed in methodology in future, especially in three domains, including participants, preciseness and applicability of the design.

Citation： LI Sheng, ZENG Xiantao, LI Xiaodong, WU Kaijie, ZI Hao, HE Dalin, WANG Xinghuan. Quality assessment of clinical practice guidelines for benign prostatic hyperplasia. Chinese Journal of Evidence-Based Medicine, 2018, 18(1): 74-80. doi: 10.7507/1672-2531.201704003 Copy

1.	Guess HA, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate, 1990, 17(3): 241-246.
2.	Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol, 1984, 132(3): 474-479.
3.	李勝, 王行環. 等離子體雙極電切系統在前列腺增生癥手術治療中的應用及研究進展. 中華臨床醫師雜志(電子版), 2011, 5(20): 6089-6093.
4.	李勝. 臨床實踐指南概述. 王行環, 主編. 循證臨床實踐指南的研發與評價(第一版). 北京: 中國協和醫科大學出版社, 2016: 1-5.
5.	Novara G, Galfano A, Gardi M, et al. Critical review of guidelines for BPH diagnosis and treatment strategy. Eur Urol Suppl, 2006, 5(4): 418-429.
6.	Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
7.	Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol, 2015, 67(6): 1099-1109.
8.	張祥華, 王行環, 王剛, 等. 良性前列腺增生臨床診治指南. 中華外科雜志, 2007, 45(24): 1704-1707.
9.	Homma Y, Gotoh M, Yokoyama O, et al. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol, 2011, 18(11): 741-756.
10.	朱剛, 王建業, 王東文, 等. 老年人良性前列腺增生/下尿路癥狀藥物治療共識. 中華老年醫學雜志, 2011, 30(11): 889-893.
11.	Cavalcanti AGLC, Errico G, Araujo JFC, et al. Hiperplasia Prostática Benigna. Brazil: Brazilian Urological Association, 2006.
12.	Tammela T, Hellstr?m P, Juusela H, et al. Eturauhasen hyv?nlaatuinen liikakasvu. Duodecim, 2006, 122: 107-108.
13.	Berges R, Dreikorn K, H?fner K, et al. Diagnostik und differenzialdiagnostik des benignen prostatasyndroms (BPS). Der Urologe, 2009, 48(11): 1356-1364.
14.	Guidelines International Network. Therapie des benignen Prostatasyndroms (BPS). Scotland: GIN, 2014.
15.	The management of lower urinary tract symptoms in men. National Institute for Health and Clinical Excellence (serial online). London: NICE, 2010 (cited 2016 Jun 5). Available at: https://www.nice.org.uk/Guidance/CG97.
16.	Cockett A, Aso Y, Denis L, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol, 1991, 1(6): 957-972.
17.	Spatafora S, Casarico A, Fandella A, et al. Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO. Ther Adv Urol, 2012, 4(6): 279-301.
18.	Lei CCM, Abdullah K, Mah P, et al. Consensus on management of benign prostatic hyperplasia. Available at: www. acadmed.org.my/view_file.cfm?fileid=221.
19.	Nickel JC, Mendez-Probst CE, Whelan TF, et al. 2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J, 2010, 4(5): 310-316.
20.	McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, 185(5): 1793-1803.
21.	Bereczky Z, Bolus M, Chetty P, et al. Management of benign prostatic hyperplasia-South African Urological Association Guideline. S Afr Med J, 2006, 96(12 Pt 3): 1275-1279.
22.	王小欽, 王吉耀, 主編. 循證臨床實踐指南的制定與實施. 北京: 人民衛生出版社, 2016.
23.	曾憲濤, 吳凡, 鄔蘭, 等. 中國口腔醫學領域臨床實踐指南的循證評價. 中國循證醫學雜志, 2015, 15(3): 264-269.
24.	邢丹, 王斌, 侯云飛, 等. 中國骨科臨床實踐指南的質量評價. 中國循證醫學雜志, 2017, 17(3): 347-356.
25.	Jiang M, Liao LY, Liu XQ, et al. Quality assessment of clinical practice guidelines for respiratory diseases in China: a systematic appraisal. Chest, 2015, 148(3): 759-766.
26.	Chen Y, Hu S, Wu L, et al. Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality. BMJ Open, 2015, 5(7): e008099.
27.	陳昊, 李廣林, 徐文韜, 等. 國內循證針灸臨床實踐指南的質量評價. 中國循證醫學雜志, 2014, 14(6): 772-775.
28.	Jin Y, Wang Y, Zhang Y, et al. Nursing practice guidelines in China do need reform: a critical appraisal using the AGREEⅡ instrument. Worldviews Evid Based Nurs, 2016, 13(2): 124-138.

1. Guess HA, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate, 1990, 17(3): 241-246.
2. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol, 1984, 132(3): 474-479.
3. 李勝, 王行環. 等離子體雙極電切系統在前列腺增生癥手術治療中的應用及研究進展. 中華臨床醫師雜志(電子版), 2011, 5(20): 6089-6093.
4. 李勝. 臨床實踐指南概述. 王行環, 主編. 循證臨床實踐指南的研發與評價(第一版). 北京: 中國協和醫科大學出版社, 2016: 1-5.
5. Novara G, Galfano A, Gardi M, et al. Critical review of guidelines for BPH diagnosis and treatment strategy. Eur Urol Suppl, 2006, 5(4): 418-429.
6. Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
7. Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol, 2015, 67(6): 1099-1109.
8. 張祥華, 王行環, 王剛, 等. 良性前列腺增生臨床診治指南. 中華外科雜志, 2007, 45(24): 1704-1707.
9. Homma Y, Gotoh M, Yokoyama O, et al. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol, 2011, 18(11): 741-756.
10. 朱剛, 王建業, 王東文, 等. 老年人良性前列腺增生/下尿路癥狀藥物治療共識. 中華老年醫學雜志, 2011, 30(11): 889-893.
11. Cavalcanti AGLC, Errico G, Araujo JFC, et al. Hiperplasia Prostática Benigna. Brazil: Brazilian Urological Association, 2006.
12. Tammela T, Hellstr?m P, Juusela H, et al. Eturauhasen hyv?nlaatuinen liikakasvu. Duodecim, 2006, 122: 107-108.
13. Berges R, Dreikorn K, H?fner K, et al. Diagnostik und differenzialdiagnostik des benignen prostatasyndroms (BPS). Der Urologe, 2009, 48(11): 1356-1364.
14. Guidelines International Network. Therapie des benignen Prostatasyndroms (BPS). Scotland: GIN, 2014.
15. The management of lower urinary tract symptoms in men. National Institute for Health and Clinical Excellence (serial online). London: NICE, 2010 (cited 2016 Jun 5). Available at: https://www.nice.org.uk/Guidance/CG97.
16. Cockett A, Aso Y, Denis L, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol, 1991, 1(6): 957-972.
17. Spatafora S, Casarico A, Fandella A, et al. Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO. Ther Adv Urol, 2012, 4(6): 279-301.
18. Lei CCM, Abdullah K, Mah P, et al. Consensus on management of benign prostatic hyperplasia. Available at: www. acadmed.org.my/view_file.cfm?fileid=221.
19. Nickel JC, Mendez-Probst CE, Whelan TF, et al. 2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J, 2010, 4(5): 310-316.
20. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, 185(5): 1793-1803.
21. Bereczky Z, Bolus M, Chetty P, et al. Management of benign prostatic hyperplasia-South African Urological Association Guideline. S Afr Med J, 2006, 96(12 Pt 3): 1275-1279.
22. 王小欽, 王吉耀, 主編. 循證臨床實踐指南的制定與實施. 北京: 人民衛生出版社, 2016.
23. 曾憲濤, 吳凡, 鄔蘭, 等. 中國口腔醫學領域臨床實踐指南的循證評價. 中國循證醫學雜志, 2015, 15(3): 264-269.
24. 邢丹, 王斌, 侯云飛, 等. 中國骨科臨床實踐指南的質量評價. 中國循證醫學雜志, 2017, 17(3): 347-356.
25. Jiang M, Liao LY, Liu XQ, et al. Quality assessment of clinical practice guidelines for respiratory diseases in China: a systematic appraisal. Chest, 2015, 148(3): 759-766.
26. Chen Y, Hu S, Wu L, et al. Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality. BMJ Open, 2015, 5(7): e008099.
27. 陳昊, 李廣林, 徐文韜, 等. 國內循證針灸臨床實踐指南的質量評價. 中國循證醫學雜志, 2014, 14(6): 772-775.
28. Jin Y, Wang Y, Zhang Y, et al. Nursing practice guidelines in China do need reform: a critical appraisal using the AGREEⅡ instrument. Worldviews Evid Based Nurs, 2016, 13(2): 124-138.

Chinese Journal of Evidence-Based Medicine

Quality assessment of clinical practice guidelines for benign prostatic hyperplasia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content